
Bristol Myers Climbs, Adobe Drops, Salesforce Gains as BofA Raises to Buy on AI Strategy
On this episode of Stock Movers:
- Bristol Myers (BMY) shares climb. Bristol Myers Squibb Co.’s experimental drugs for treating a rare endocrine cancer and a deadly form of lung disease showed promise in late-stage studies, a potential boon for the pharmaceutical company’s new product pipeline. Wall Street has been eagerly anticipating both results, as the drugs use novel approaches for hard-to-treat conditions that impair patients’ quality of life and are eventually fatal.
- Adobe (ADBE) shares drop. Wells Fargo Securities downgraded the maker of software for creative…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.